scholarly journals The role of high-flow nasal cannulae oxygenation

2022 ◽  
Vol 10 (3) ◽  
Author(s):  
Stefano DE VUONO ◽  
Maria R. TALIANI ◽  
Sokol BERISHA ◽  
Pasquale CIANCI ◽  
Alessandra LIGNANI ◽  
...  
Keyword(s):  
2021 ◽  
Vol 16 (6) ◽  
pp. 1374-1377
Author(s):  
Ayyaz Quddus ◽  
Priyesh Karia ◽  
Ruhaid Khurram ◽  
Arum Parthipun ◽  
Jocelyn Brookes

2017 ◽  
Vol 58 (4) ◽  
pp. 295-302 ◽  
Author(s):  
Ke-Yun Chao ◽  
Yi-Ling Chen ◽  
Li-Yi Tsai ◽  
Yu-Hsuan Chien ◽  
Shu-Chi Mu

2020 ◽  
pp. 00711-2020
Author(s):  
W. R. Good ◽  
J. Garrett ◽  
H.-U. P. Hockey ◽  
L. Jayaram ◽  
C. Wong ◽  
...  
Keyword(s):  

2020 ◽  
Vol 9 (12) ◽  
pp. 3832
Author(s):  
Massa Zantah ◽  
Aloknath Pandya ◽  
Michael R. Jacobs ◽  
Gerard J. Criner

High-flow nasal therapy (HFNT) is a unique system that delivers humidified, heated oxygen-enriched air via nasal cannula at high flow rates. It is a promising therapy for chronic obstructive pulmonary disease (COPD) patients. Several studies have examined the physiologic effects of this therapy in the patient population and have revealed that it improves mucociliary clearance, reduces nasopharyngeal dead space, and subsequently increases CO2 washout. It also improves alveolar recruitment and gas exchange. These mechanisms may explain the promising results observed in recently published studies that examined the role of HFNT in stable COPD patients.


Sign in / Sign up

Export Citation Format

Share Document